GUARDANT HEALTH, INC. (GH) Payables and obligations
- Other obligations · latest quarter (USD): Value (m); Formula and calculation Total liabilities − borrowing debt − payables − total deferred revenue. Includes accruals, taxes, leases and other obligations; excludes the separately shown balances. Period ending 2026-06-30..
- Payables · latest quarter (USD): Value $93.51M; Formula and calculation Amounts owed to suppliers, reported accounts payable. Period ending 2026-06-30..
- Deferred revenue · latest quarter (USD): Value $52.00M; Formula and calculation Current and noncurrent customer contract obligations; payments received before revenue is earned. Period ending 2026-06-30..
- Other obligations · due within 1 year (USD): Value (m); Formula and calculation Reported other current liabilities. Excludes separately reported debt, payables and current deferred revenue. The saved current-quarter facts do not separately disclose taxes, payroll, leases or accruals. Period ending 2026-06-30..
Payables and obligations
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Other obligations · latest quarter (USD) | (m) | Total liabilities − borrowing debt − payables − total deferred revenue. Includes accruals, taxes, leases and other obligations; excludes the separately shown balances. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Payables · latest quarter (USD) | $93.51M | Amounts owed to suppliers, reported accounts payable. Period ending 2026-06-30. Reported amount: $93.51M |
| Deferred revenue · latest quarter (USD) | $52.00M | Current and noncurrent customer contract obligations; payments received before revenue is earned. Period ending 2026-06-30. $44.79M + $7.20M ≈ $52.00M |
| Other obligations · due within 1 year (USD) | (m) | Reported other current liabilities. Excludes separately reported debt, payables and current deferred revenue. The saved current-quarter facts do not separately disclose taxes, payroll, leases or accruals. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Other obligations · due after 1 year (USD) | $126.94M | Reported other noncurrent liabilities minus the noncurrent deferred revenue they include (total customer contract obligations − current portion); a separately reported noncurrent deferred revenue line is not deducted. The saved current-quarter facts do not separately disclose taxes, leases or other accruals. Period ending 2026-06-30. $126.94M − $0.00 ≈ $126.94M |
Calculation inputs
Other obligations breakdown
- Other obligations · due within 1 year (USD)
- (m)
- Other obligations · due after 1 year (USD)
- $126.94M
Bonds and commercial paper are already included in Total debt. Other obligations include taxes, accrued expenses and operating/finance leases. Category amounts below are the issuer’s own tagged balances at the same quarter end; untagged categories are not shown.
| Category | Quarter ending 2026-06-30 |
|---|---|
| Operating lease obligations | $194.07M |
These categories are parts of the combined obligations, not additional deductions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Other obligations | Payables | Deferred revenue | Short-term obligations | Long-term obligations | Total reported obligations (USD) | Borrowing debt (USD) | Deferred revenue due within one year (USD) | Deferred revenue due after one year (USD) | Reported other noncurrent obligations (USD) | Deferred revenue included in other noncurrent obligations (USD) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $93.51M | $52.00M | (m) | $126.94M | $2.14B | (m) | $44.79M | $7.20M | $126.94M | $0.00 |
| 2026-03-31 | (m) | $75.03M | $56.70M | (m) | $127.69M | $2.10B | (m) | $47.77M | $8.90M | $127.69M | $0.00 |
| 2025-12-31 | (m) | $54.44M | $59.70M | (m) | $127.77M | $2.11B | (m) | $50.75M | $9.00M | $127.77M | $0.00 |
| 2025-09-30 | (m) | $20.14M | $56.40M | (m) | $94.36M | $1.63B | (m) | $46.86M | $9.50M | $94.36M | $0.00 |
| 2025-06-30 | (m) | $44.80M | $60.70M | (m) | $91.17M | $1.64B | (m) | $54.35M | $6.40M | $91.17M | $0.00 |
| 2025-03-31 | (m) | $49.77M | $44.00M | (m) | $92.55M | $1.60B | (m) | $36.30M | $7.70M | $92.55M | $0.00 |
| 2024-12-31 | (m) | $38.55M | $41.60M | (m) | $92.83M | $1.63B | (m) | $35.47M | $6.10M | $92.83M | $0.00 |
| 2024-09-30 | (m) | $15.47M | $32.50M | (m) | $89.45M | $1.60B | (m) | $29.55M | $3.00M | $89.45M | $0.00 |
| 2024-06-30 | (m) | $42.45M | $35.40M | (m) | $95.93M | $1.61B | (m) | $29.38M | $6.00M | $95.93M | $0.00 |
| 2024-03-31 | (m) | $37.60M | $27.80M | (m) | $96.79M | $1.64B | (m) | $22.56M | $5.30M | $96.79M | $0.00 |
| 2023-12-31 | (m) | $51.74M | $22.90M | (m) | $96.01M | $1.63B | (m) | $17.96M | $5.00M | $96.01M | $0.00 |
| 2023-09-30 | (m) | $77.83M | $24.40M | (m) | $10.18M | $1.57B | (m) | $21.48M | $2.90M | $10.18M | $0.00 |
| 2023-06-30 | (m) | $79.78M | $15.10M | (m) | $9.45M | $1.55B | (m) | $12.24M | $2.90M | $9.45M | $0.00 |
| 2023-03-31 | (m) | $67.32M | $17.10M | (m) | $9.14M | $1.56B | (m) | $13.62M | $3.40M | $9.14M | $0.00 |
| 2022-12-31 | (m) | $68.91M | $21.20M | (m) | $9.18M | $1.55B | (m) | $17.40M | $3.80M | $9.18M | $0.00 |
| 2022-09-30 | (m) | $40.91M | $15.40M | (m) | $6.99M | $1.54B | (m) | $13.42M | $2.00M | $6.99M | $0.00 |
| 2022-06-30 | (m) | $36.97M | $17.30M | (m) | $9.29M | $1.53B | (m) | $14.96M | $2.30M | $9.29M | $0.00 |
| 2022-03-31 | (m) | $32.23M | $10.60M | (m) | $6.88M | $1.60B | (m) | $10.57M | $30.00K | $6.91M | $30.00K |
| 2021-12-31 | (m) | $17.58M | $11.30M | (m) | $3.96M | $1.56B | (m) | $11.33M | $-26.00K | $3.93M | $-26.00K |
| 2021-09-30 | (m) | $15.67M | $7.30M | (m) | $3.44M | $1.46B | (m) | $7.32M | $-17.00K | $3.42M | $-17.00K |
| 2021-06-30 | (m) | $21.40M | $8.50M | (m) | $2.47M | $1.44B | (m) | $8.48M | $20.00K | $2.49M | $20.00K |
| 2021-03-31 | (m) | $22.32M | $8.40M | (m) | $1.61M | $1.44B | (m) | $8.36M | $40.00K | $1.65M | $40.00K |
| 2020-12-31 | (m) | $7.34M | $8.60M | (m) | $1.47M | $916.19M | (m) | $8.55M | $50.00K | $1.52M | $50.00K |
| 2020-09-30 | (m) | $18.28M | $7.30M | (m) | $1.89M | $113.50M | (m) | $7.34M | $-37.00K | $1.86M | $-37.00K |
| 2020-06-30 | (m) | $15.98M | $11.50M | (m) | $1.37M | $112.55M | (m) | $11.48M | $15.00K | $1.38M | $15.00K |
| 2020-03-31 | (m) | $24.38M | $11.90M | (m) | $1.50M | $117.55M | (m) | $11.94M | $-36.00K | $1.46M | $-36.00K |
| 2019-12-31 | (m) | $16.20M | $12.30M | (m) | $1.65M | $114.54M | (m) | $12.28M | $23.00K | $1.67M | $23.00K |
| 2019-09-30 | (m) | $12.05M | $13.10M | (m) | $1.22M | $86.44M | (m) | $13.10M | $5.00K | $1.22M | $5.00K |
| 2019-06-30 | (m) | $15.70M | $16.50M | (m) | $1.30M | $77.72M | (m) | $16.50M | $4.00K | $1.30M | $4.00K |
| 2019-03-31 | (m) | $7.16M | $17.10M | (m) | $163.00K | $64.54M | (m) | $17.11M | $-13.00K | $150.00K | $-13.00K |
| 2018-12-31 | (m) | $10.64M | $16.10M | (m) | $244.00K | $62.45M | (m) | $16.14M | $-38.00K | $206.00K | $-38.00K |
| 2018-09-30 | (m) | $13.08M | $4.00M | (m) | $161.00K | $47.46M | (m) | $3.96M | $45.00K | $206.00K | $45.00K |
| 2017-12-31 | (m) | $5.00M | $3.10M | (m) | $13.00K | $34.33M | (m) | $3.11M | $-13.00K | $0.00 | $-13.00K |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |